About us
Dr. Pinaki Mukhopadhyay
D.M. (Nephrology)
Academic Qualifications
- M.B.B.S. [Calcutta University]
- D.C.H. [Calcutta University]
- M.D. (General Medicine) [Calcutta University]
- D.M. (Nephrology) [PGIMER, Chandigarh]
- FICP (Fellowship of Indian College of Physician) in 2017
- FASN (Fellow of the American Society of Nephrology) in 2018
- FRCP (London) (Fellow of Royal College of Physician) in 2022
- FISN (Fellow of Indian Society of Nephrology) in 2025
Overview
Prof. (Dr.) Pinaki Mukhopadhyay is a Kolkata-based nephrologist. He completed M.B.B.S., M.D. (General Medicine) at Calcutta University and D.M. (Nephrology) at PGIMER, Chandigarh. He is Professor and Head, Department of Nephrology, NRS Medical College & Hospital, Kolkata.
Published 20+ original articles and multiple abstracts, authored book chapters, and actively contributes to national and international nephrology conferences as speaker, judge, moderator, and reviewer.
Honors and Awards
Dr Bonomali Chakrabarty Memorial Medal
Awarded with “Dr Bonomali Chakrabarty Memorial Medal” in Pharmacology.
Dr S. N Chatterjee Memorial Medal
Awarded with “Dr S. N Chatterjee Memorial Medal” for Clinical Surgery.
Achievements
Research
Publications
Achievements
- Published 20+ original articles and multiple abstracts; authored book chapters in nephrology.
- Upgraded dialytic services and initiated dialysis technician course and nurses’ training at NRS Medical College, Kolkata.
- Examiner for West Bengal State Medical Faculty, DNB Board, and DM (Nephrology) examinations.
- Guide/co-guide for postgraduate, PhD, and post-doctoral students; supervised multiple DM theses.
- Reviewer for JIMA, IJT, JAPI, and IJN journals.
- Assessor for DNB, NMC, DM courses, and transplant centers.
- Hands-on training programs for CAPD catheterization and peritoneal dialysis (adult and pediatric).
- Editor of Macmaster Textbook of Internal Medicine; contributed to APICON Update Book (2025).
- Established DM Nephrology student exchange program with institutions across India.
Research
- Progression of chronic kidney disease from acute kidney injury following snake envenomation markers for risk stratification (Dept. of Higher Education, Science & Technology and Biotechnology, Govt. of West Bengal).
- ALIGN Study: Phase 3 randomized double-blind placebo-controlled study of Atrasentan in IgA nephropathy at risk of progressive loss of renal function.
- DREAM ND: Desidustat in anemia due to non-dialysis dependent chronic kidney disease (Phase 3).
- TANGIBLE: Urgent Translational Glomerulonephritis Biology Network studies on primary glomerular disease (Co-PI).
- DREAM D: Desidustat in anemia due to dialysis-dependent chronic kidney disease (Phase 3).
- REMIT Trial: Randomized clinical trial comparing obinutuzumab/calcineurin inhibitor to corticosteroid plus cyclophosphamide in primary membranous nephropathy.
- Phase 3 study: Ferric pyrophosphate citrate via dialysate to maintain hemoglobin concentration in CKD patients on hemodialysis (ICR/21/010).
- Phase 3 study: Study treatment with systemic antibiotics for catheter-related or central line associated bloodstream infection.
- Phase 2 study: Finerenone plus empagliflozin vs either alone in CKD with type 2 diabetes (Protocol 21839 V1.0, 15 Nov 2021; awaiting ethics approval).
- TRACK: Phase 3 trial of low-dose rivaroxaban in advanced CKD.
- BION-1301: Phase 3 randomized double-blind placebo-controlled study in adults with IgA nephropathy (CHK02-02).
- Phase III: Baxdrostat + dapagliflozin vs dapagliflozin alone on renal outcomes and CV mortality in CKD with high blood pressure.
- Phase 2b/3: Atacicept in IgA nephropathy.
- FIONA: Finerenone regimen in children (6 months to <18 years) with CKD and proteinuria.
- BI 690517 + empagliflozin: Heart & kidney protection study in CKD.
- PREVAIL: Felzartamab in adults with IgA nephropathy (Phase 3).
- Open-label Phase 3: Felzartamab in primary membranous nephropathy.
Publications
- Mukhopadhyay P#, Mishra R, Mukherjee D, Mishra R, Kar M. Snakebite mediated acute kidney injury, prognostic predictors, oxidative and carbonyl stress - a prospective study. Indian J Nephrol. 2016 Nov-Dec;26(6):427-433. (# Corresponding author)
- Rathi M, Bhagat RL, Mukhopadhyay P, Kohli HS, Jha V, Gupta KL, Sakhuja V, Joshi K. Changing histologic spectrum of adult nephrotic syndrome over five decades in north India: a single center experience. Indian J Nephrol. 2014 Mar;24(2):86-91.
- Mukherjee D, Mishra R, Chakraborty M, Mukherjee P, Kar M, Mishra R. Evaluation of carbonyl stress as the principal etiological factor of protein damage in chronic renal failure patients on maintenance hemodialysis. Indian Journal of Physiology and Allied Sciences. 2013 Apr;67(2):59-65.
- Mukhopadhyay P, Rathi M, Kohli HS, Jha V, Gupta KL, Sakhuja V. Polyarteritis nodosa presenting with spontaneous perirenal hematoma. Indian J Nephrol. 2012 Jul;22(4):295-297.
- Mukhopadhyay P, Kumar V, Rathi M, Kohli HS, Jha V, Sakhuja V. Transmission of human immunodeficiency virus infection by renal transplantation. Indian J Nephrol. 2012 Mar;22(2):133-135.
- Mukhopadhyay P, Kundu SS, Banerjee A, Mukherjee A. Adult hepatoblastoma in a female with Down's. J Assoc Physicians India. 2007 Mar;55:242-243.
- Mukhopadhyay P. Delayed presentation of a massive sub-capsular haematoma of the spleen. Indian Journal of Surgery. 2003;65(5):445-446.
- Mukhopadhyay P, Das P, Guha G. Study of spectrum of movement disorder in chronic kidney disease. EJPMR. 2017;4(6):766-786.
- Mukhopadhyay P, Vasudha, Saha SP, Biswas NM. Nerve dysfunction in patient with end stage renal disease and causative role of potassium - a hospital based study. International Journal of Current Research. 2017 Jul;9(7):54050-54056.
- Mukhopadhyay P, Das S. Long-term outcome of viper venom induced nephrotoxicity in murine model. Kidney International Reports. 2020;5(S1):S392.
- Mukhopadhyay P, Banerjee R. Risk factor assessment in progression of snake venom induced acute kidney injury to chronic kidney disease. Kidney International Reports. 2020;5(S1):S3.
- Mukhopadhyay P, Ghosh S, Bal R. Renal outcome of pregnancy associated kidney injury needed hemodialysis. IJAR. Vol 9, Issue 5.
- Mukhopadhyay P, Aich T. Urine microscopy - a golden tool in characterizing acute kidney injury. IJBAMR. Sept 2017;6(4):161-171.
- Mukhopadhyay P, Patar K, Chatterjee N. Effect of vitamin D deficiency on cardiac structure and function in pre-dialysis diabetic and non-diabetic chronic kidney disease. IJBAMR. Dec 2017;7(1):400-413.
- Banerjee R, Banerjee P, Mishra R, Mishra R, Mukhopadhyay P. Epidemiology and clinical features of snake bite induced AKI patients in last decade and its long-term outcome - a single center experience. Indian J of Applied Research. 2022 Jan;12(1):18-21.
- Desidustat in anemia due to non-dialysis dependent chronic kidney disease: Phase 3 study (DREAM ND). Am J Nephrol. 2022 Apr; DOI 10.1159/000523961.
- Mukhopadhyay P. Evaluation and outcome of tropical kidney injury in a tertiary care hospital in eastern India. Kidney International Reports. 2022.
- Banerjee R, Mukhopadhyay P, Mishra R, Mishra R. Development of chronic kidney disease from snake bite induced acute kidney injury - risk assessment. Kidney International Reports. 2022;7(9 Suppl):S530.
- Kargupta A, Dasgupta S, Mukhopadhyay P. Comparative study between single dose rituximab therapy vs multiple dose regimen in idiopathic membranous nephropathy and its correlation with peripheral blood CD19 count. Kidney International Reports. 2022.
- Mukhopadhyay P, Khan J, Banerjee P, Bhattacharya P, Kataruka M, Datta S. Post mortem renal pathological changes in snake bite patients and association with clinical features. J Indian Med Assoc. 2023;121(8):71-74.
- Yadav K, Ramachandran R, Kumar V, et al. Indian Translational Glomerulonephritis Biology Network (I-TANGIBLE): design and methods. Indian J Nephrol. 2023;33(4):277-282.
- Meena P, Beniwal P, et al. Study design of a nationwide network Indian cohort of pregnancy associated acute kidney injury (iPRAKI NET). Kidney International Reports. 2025.
- Mukhopadhyay P, Patel A, Bal R, Sarkar K, Mukhopadhyay G, Maity A. WCN 25-1133 clinical profile and outcome of pregnancy related acute kidney injury in eastern part of India. 2025;10(2):11-12.
- Mukhopadhyay P, Banerjee R, Mishra R, Mishra R. WCN 25-1422 study of biomarkers predictive in snakebite AKI (SAKI) to chronic kidney disease. 2025;10(2):11-12.
- Banerjee B, Mukhopadhyay P, Karmakar D, Mondol K, Mukherjee D, Maity A. WCN 25-26009 predictor and long-term outcome of snakebite associated AKI (SAKI) in eastern India. 2025;10(2):40-41.
- Gupta SD, Mukhopadhyay P, Ghosh S, Chatterjee N, Sarkar A. WCN 25-1744 potential role of waist circumference and renal sinus fat as non-invasive predictors for early diagnosis of renal dysfunction in overweight and obese patients. 2025;10(2):163-165.
- Chafekar D, Mukhopadhyay P, Ambekar N, et al. Torsemide in edema associated with chronic kidney disease. J Assoc Physicians India. 2024;10:595556/japi.72.0674.
MEDICAL EXCELLENCE, COMPASSIONATE CARE
What We Stand For
Our Code Values
At Dr. Pinaki Mukhopadhyay’s practice, we are dedicated to providing top-tier nephrology care with a compassionate and personalized approach.
Excellence in Nephrology Care
Commitment to delivering the highest standard of kidney care through expertise, research, and continuous learning.
Patient-Centered Approach
Fostering a compassionate, empathetic environment where each patient receives personalized attention and care.
Innovative Medical Solutions
Embracing cutting-edge research and technology to offer innovative treatments and solutions in nephrology.
Collaboration and Teamwork
Working closely with patients, families, and healthcare professionals to ensure comprehensive care and support.
Education and Knowledge Sharing
Continuously contributing to the field of nephrology through research, publications, and education to advance medical knowledge and practice.
Trust and Integrity
Building long-term relationships based on trust, transparency, and ethical medical practices, ensuring patients feel valued and respected.
GREAT PRACTICE MEANS GREAT HEALTH CARE
Medicare in numbers
Dynamically target high-payoff intellectual capital for customized technologies. Objectively integrate emerging core competencies.
HEALING SUCCESS
Progressively maintain extensive infomediaries via extensible niches.
OPERATIONAL SUCCESS
Efficiently enable enabled sources and cost effective products.
DEDICATION FOR PATIENT
Progressively maintain extensive infomediaries via extensible niches.
CARE EXPRESSED
Efficiently innovate open-source infrastructures via inexpensive materials.
Get in touch
For renal transplant, hemodialysis, arteriovenous fistula, IJV catheterization, or any other kidney-related
conditions, get in touch with us today.
conditions, get in touch with us today.
ADDRESS
27th Avenue
New York, W2 3XE, US
New York, W2 3XE, US
CALL US
0-800-2336-7820
0-800-2344-6477
0-800-2344-6477
WRITE TO US
office@medicare.com
book@medicare.com
book@medicare.com
BOOK AN APPOINTMENT
Click here to book an
appointment at Medicare.